MCRB
Price
$17.71
Change
-$3.99 (-18.39%)
Updated
Nov 21 closing price
Capitalization
159.49M
Intraday BUY SELL Signals
NRIX
Price
$16.76
Change
+$1.43 (+9.33%)
Updated
Nov 21 closing price
Capitalization
1.7B
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MCRB vs NRIX

Header iconMCRB vs NRIX Comparison
Open Charts MCRB vs NRIXBanner chart's image
Seres Therapeutics
Price$17.71
Change-$3.99 (-18.39%)
Volume$472.08K
Capitalization159.49M
Nurix Therapeutics
Price$16.76
Change+$1.43 (+9.33%)
Volume$2.33M
Capitalization1.7B
MCRB vs NRIX Comparison Chart in %
MCRB
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MCRB vs. NRIX commentary
Nov 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCRB is a Hold and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 22, 2025
Stock price -- (MCRB: $17.63 vs. NRIX: $16.76)
Brand notoriety: MCRB and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MCRB: 244% vs. NRIX: 144%
Market capitalization -- MCRB: $159.49M vs. NRIX: $1.7B
MCRB [@Biotechnology] is valued at $159.49M. NRIX’s [@Biotechnology] market capitalization is $1.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCRB’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 0 green FA rating(s).

  • MCRB’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 0 green, 5 red.
According to our system of comparison, both MCRB and NRIX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCRB’s TA Score shows that 4 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • MCRB’s TA Score: 4 bullish, 6 bearish.
  • NRIX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than MCRB.

Price Growth

MCRB (@Biotechnology) experienced а +5.82% price change this week, while NRIX (@Biotechnology) price change was +30.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +62.87%.

Reported Earning Dates

NRIX is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($1.7B) has a higher market cap than MCRB($159M). MCRB YTD gains are higher at: 6.077 vs. NRIX (-11.040). MCRB has higher annual earnings (EBITDA): -49.22M vs. NRIX (-248.7M). NRIX has more cash in the bank: 429M vs. MCRB (45.4M). NRIX has less debt than MCRB: NRIX (56.5M) vs MCRB (87.4M). NRIX has higher revenues than MCRB: NRIX (83.7M) vs MCRB (0).
MCRBNRIXMCRB / NRIX
Capitalization159M1.7B9%
EBITDA-49.22M-248.7M20%
Gain YTD6.077-11.040-55%
P/E Ratio20.03N/A-
Revenue083.7M-
Total Cash45.4M429M11%
Total Debt87.4M56.5M155%
FUNDAMENTALS RATINGS
MCRB: Fundamental Ratings
MCRB
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
14
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MCRBNRIX
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
MCRB
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMGDF0.850.09
+11.53%
Aston Martin Lagonda Global Holdings plc.
AVVIY17.060.25
+1.49%
Aviva Plc
TMASF0.13N/A
+1.34%
Temas Resources Corp.
BVERS2650.01N/A
N/A
Beaver Coal Co., Ltd.
PSBAF0.12N/A
N/A
PT Sumber Alfaria Trijaya TBK

MCRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCRB has been loosely correlated with ORMP. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MCRB jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCRB
1D Price
Change %
MCRB100%
-18.76%
ORMP - MCRB
42%
Loosely correlated
+6.82%
AXON - MCRB
38%
Loosely correlated
+0.46%
AMRN - MCRB
36%
Loosely correlated
-0.30%
ARRY - MCRB
34%
Loosely correlated
+6.81%
TAOX - MCRB
34%
Loosely correlated
+5.61%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+9.33%
KYMR - NRIX
63%
Loosely correlated
+2.44%
IDYA - NRIX
56%
Loosely correlated
+2.50%
TYRA - NRIX
55%
Loosely correlated
+0.57%
DNLI - NRIX
55%
Loosely correlated
+4.87%
RLAY - NRIX
55%
Loosely correlated
+6.11%
More